Toronto Public Health is encouraging residents to get vaccinated after cases of mpox clade Ib were confirmed in Toronto and Ontario.
DENVER — Studies published in a medical journal and presented at a conference showed that tecovirimat did not increase clinical resolution of mpox and may contribute to antiviral resistance for people ...
An international, randomized, double-blind, placebo-controlled Phase III study—the largest of its kind for mpox—found that tecovirimat did not improve clinical outcomes for adults with clade II mpox ...
SHELTON, CT / ACCESS Newswire / July 14, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of ...
Colorized transmission electron micrograph of immature mpox virus particles (blue with red viral envelope) found within an infected VERO E6 cell (yellow), cultured in the laboratory. Image captured at ...
Mpox (formally Monkeypox) is a viral disease caused by the Monkeypox virus and can infect both humans and animals. Interestingly, this is part of the viral family linked to smallpox. Patients that ...
Toronto Public Health is asking people to ensure they're vaccinated if eligible to prevent transmission, with officials ...
antiviral effectiveness of the drug in patients. The overall clinical trial will enroll approximately 80 patients. “This is an important milestone towards filing of the clinical trial application and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results